Top 20 Medical VC Funds & Investors in Portugal (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Portugal Ventures
VC Fund
|
9 | Portugal, United States, France | Seed, Pre-Seed | Software, Information Technology, Health Care | $110k–$2.1M |
|
Armilar Venture Partners
VC Fund
|
5 | Portugal, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $500k–$16M |
|
Vesalius Biocapital Partners
VC Fund
|
4 | Belgium, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$100M |
|
Caixa Capital
VC Fund
|
3 | Portugal, United States, Spain | Seed, Series A | Software, Information Technology, SaaS | $120k–$12M |
|
TheVentureCity
VC Fund
|
3 | United States, Spain, Brazil | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $100k–$45M |
|
Biovance Capital
VC Fund
|
3 | Portugal, The Netherlands | Seed, Series A | Medical, Biotechnology, Product Research | |
|
Critical Ventures
VC Fund
|
2 | Portugal, United States | Seed, Series A | Medical, Computer, Genetics | $1.2M–$13M |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
ChangePartners
VC Fund
|
1 | Portugal | Seed | Medical, Therapeutics, Biotechnology | |
|
Social Impact Fund
VC Fund
|
1 | Spain, Portugal, United States | Seed, Debt Financing | Apps, Video, Finance | $942k–$2.5M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Boule Diagnostics
VC Fund
|
1 | Portugal | Series A | Medical, Health Care, Medical Device | |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Torrey Pines Investment
VC Fund
|
1 | United States, Russian Federation, The Netherlands | Seed, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $3M–$3.1M |
|
Demium Capital
VC Fund
|
1 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, FinTech, Health Care | $110k–$3.1M |
|
Green Innovations
VC Fund
|
1 | Portugal | Series A | Medical, Genetics, Health Care | |
|
Iberis Capital
VC Fund
|
1 | Portugal, United States, Spain | Series A, Seed | Information Technology, Software, SaaS | $2.2M–$43M |
|
Shilling VC
VC Fund
|
1 | Portugal, Spain, United States | Seed, Pre-Seed, Series A | Information Technology, Software, Internet | $208k–$20M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
1 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $994k–$40M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
| Access all 35 VC funds in Portugal Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: Portugal, United States, France
Investor stats
- Total investments: 226
- Round size: Seed $110k–$2.1M; Pre-Seed $110k–$658k
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — last raise in 2011
Portfolio highlights
- Azulfy — Real-time pollution monitoring for EU municipalities. Satellite-based environmental compliance tools for local governments and smart cities.
- PLUTOS — We are here to make sure that your Puppy gets the best treat! PLUTOS were created specifically for dogs to have fun. Find out our dog healthy chews.
- Hostels HUB — Hostels HUB is a hostel developer that is looking for opportunities both in city as leisure locations around Portugal.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 102
- Round size: Seed $500k–$4.8M; Series A $4M–$16M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $53M in 2019
Portfolio highlights
- Equall — Equall offers legal AI systems to help companies and lawyers evaluate and control risk.
- DOJO AI — Dojo AI is pioneering the Marketing Operating System (MOS) category, providing challenger brands with enterprise-grade marketing infrastructure. Its proprietary technology combines real-time market intelligence, specialized AI agents, and automated workflow orchestration in one unified platform.The Dojo MOS enables marketing teams to run theirentire operation - from market research and strategy to content creation and campaign execution - through a single, intelligent system. The platform features a proprietary graph engine for real-time market intelligence, marketing-specific language models, and autonomous AI agents trained for specialized marketing tasks.Built for challenger brands looking to compete more effectively, Dojo eliminates the need for multiple point solutions and reduces dependency on external agencies. The platform continuously learns and optimizes, providing companies with compounding advantages as they scale their marketing operations.
- DareData —
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, France
Investor stats
- Total investments: 60
- Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $7M–$100M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 67
- Round size: Seed $120k–$2.5M; Series A $3M–$12M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- BioMimetx — BioMimetx is a biotech startup focused on the development of green antifouling solutions to prevent marine biofouling. The company discovers and owns environmental bacteria that secrete molecules, which are used as natural antimicrobials and algaecides. BioMimetx is based in Cantanhede, Portugal.
- Movvo — The Movvo platform delivers smart business intelligence solutions for owners and operators of retail and commercial real estate that turns data into improved retail performance and better value engineering decisions. The platform combines consumer behaviour wireless sensor technology and digests other public and private datasets, enhancing theunderstanding of the data by applying machine learning to provide fast and easy interpretation of this data delivering insights and rapid scenario-planning. Whether it is measuring ROI or reporting KPI's, the Movvo platform has these bases covered. Where it comes into its own is via the application of machine learning Want to easily prepare a leasing pack that maximises the rental value, what to create additional incremental value from asset investment decisions, want to know the impact of changing the tenant from apparel retailer to food & beverage? The Movvo platform can deliver prescriptive intelligence and more.
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
TheVentureCity is a global early-stage venture fund, investing in product-centric startups across the US, Europe, and Latam. With more than $150M under management, the firm invests from pre-seed and seed with a ticket size from $100-500k to Series A with $1-4M.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Spain, Brazil
Investor stats
- Total investments: 135
- Round size: Seed $100k–$4.9M; Pre-Seed $100k–$1.2M; Series A $3M–$45M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Devengo — Light-speed transfers. Our Instant Payments API enables seamless integration to automate payouts to your customers in Europe and the UK.
- Argo — Argo is a transit technology and services company that provides an integrated public transportation system, combining electric vehicles, intelligent routing software, and operational management to offer on-demand transit services. Its products and services include smart routing technology, EV transit vehicles, and mobile app-based ride matching forcommunities.
- Belo — Crypto for everyone, everyday
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).
Show more...Investment focus
- Industry: Medical, Biotechnology, Product Research
- Stage:Seed, Series A
- Geography: Portugal, The Netherlands
Investor stats
- Total investments: 4
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Laigo Bio — Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
We invest in game-changing companies with the power to transform the way the world uses technology.
Show more...Investment focus
- Industry: Medical, Computer, Genetics
- Stage:Seed, Series A
- Geography: Portugal, United States
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$13M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- hOS — hOS is an early-stage AI technology company.
- Kirontech — Detect & manage wasteful practices
- RunSafe Security — Secure embedded systems with RunSafe Security's runtime cybersecurity protection, integrating build-time defenses without affecting performance.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market. They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
Show more...Investment focus
- Industry: Medical, Therapeutics, Biotechnology
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more...Investment focus
- Industry: Apps, Video, Finance
- Stage:Seed, Debt Financing
- Geography: Spain, Portugal, United States
Investor stats
- Total investments: 4
- Round size: Seed $942k–$2.5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
- tuTECHÔ — tuTECHÔ is an innovative social enterprise born with the purpose of contributing to the eradication of homelessness in Spain.
- MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 227
- Round size: Seed $120k–$5M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Boule develops, manufactures, and markets hematology analyzers for both human and veterinary markets. Read more about us here.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Biosurfit — At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 589
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: United States, Russian Federation, The Netherlands
Investor stats
- Total investments: 32
- Round size: Seed $3M–$3.1M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $60M in 2017
Portfolio highlights
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
- BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
- Avelas Biosciences — At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 83
- Round size: Seed $110k–$3.1M; Pre-Seed $110k–$450k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Qalea —
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- KomboAI — Supercharge your CRM and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. Book a Demo See Kombo in Action Over 1000+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right leads Receive every day new leads
International, Life Sciences, Biotechnology
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CBR Genomics — We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
Iberis is an investment manager that operates a value-oriented investment management.
Show more...Investment focus
- Industry: Information Technology, Software, SaaS
- Stage:Series A, Seed
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 36
- Round size: Seed $2.2M–$3.2M; Series A $6M–$43M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- TEKEVER — The Tekever Group is a provider of innovative technologies in Software, Aerospace, Defence and Security Markets.
- Connected — Connected is a startup that offers affordable connecting humans, unleashing a new wave of IoT-based business models and contributing to bridge the digital gap.
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Shilling is an early-stage venture capital firm backing exceptional founders from the start.Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, directaccess to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 85
- Round size: Seed $603k–$5M; Pre-Seed $208k–$3M; Series A $5M–$20M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Algori — Improving FMCG growth with the fastest and most granular insights from 45,000 shoppers in Spain
- Musiversal — Record your music in real time with world-class session musicians, vocalists, producers and audio engineers
- Punto Health — AI-Powered, Personalised Support for Every Patient and Family
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 557
- Round size: Seed $994k–$7.4M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- QphoX — QphoX builds quantum modem device, connecting quantum computers across a quantum network.
- Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
- Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
Medical VC funding in Portugal at a glance
Stats across 31 deals from 35 investors.
Access all 35 VC funds in Portugal Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Portugal investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 35 VC funds investing in Portugal Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!